Table 3.
Prevalence ratios for clinic hypertension, daytime hypertension, and sustained hypertension associated with diabetes among Jackson Heart Study participants taking antihypertensive medication.
| No Diabetes | Diabetes | |
|---|---|---|
| Clinic Hypertension | N=371 | N=196 |
| Prevalence, n (%) | 110 (29.7%) | 55 (28.1%) |
| Prevalence ratio (95% CI) | ||
| Model 1 | 1 (ref) | 0.94 (0.72–1.23) |
| Model 2 | 1 (ref) | 0.93 (0.71–1.23) |
| Model 3 | 1 (ref) | 0.92 (0.70–1.22) |
| Daytime Hypertension | N=371 | N=196 |
| Prevalence, n (%) | 148 (39.9%) | 96 (49.0%) |
| Prevalence ratio (95% CI) | ||
| Model 1 | 1 (ref) | 1.21 (1.00–1.46) |
| Model 2 | 1 (ref) | 1.26 (1.05–1.53) |
| Model 3 | 1 (ref) | 1.32 (1.09–1.60) |
| Sustained Hypertension | N=110 | N=55 |
| Prevalence, n (%) | 71 (64.6%) | 41 (74.6%) |
| Prevalence ratio (95% CI) | ||
| Model 1 | 1 (ref) | 1.08 (0.77–1.51) |
| Model 2 | 1 (ref) | 1.07 (0.76–1.51) |
| Model 3 | 1 (ref) | 1.12 (0.78–1.60) |
CI: confidence interval
See Table 1 for the definitions of clinic hypertension, daytime hypertension and sustained hypertension.
Model 1 is adjusted for age and sex.
Model 2 is adjusted for variables in Model 1 + education, marital status, current smoking, physical activity, BMI.
Model 3 is adjusted for variables in Model 2 + history of stroke, history of myocardial infarction, total and HDL-cholesterol, and taking ≥ 3 classes of antihypertensive medications.